Stay updated on Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:49:40.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A notice appears above the page announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-26T14:13:47.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov 403 error page remains the same, while its footer revision number advances from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:07:40.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The displayed site revision changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:34:45.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error, replacing the study details with an error page. The added content includes the 403 header and standard navigation seen on access-denied pages.
    Difference
    21%
    Check dated 2026-09-21T20:37:51.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    There are no listed text changes for this page; the content remains as in the current version.
    Difference
    0.1%
    Check dated 2026-09-07T20:44:07.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.